Imagion Biosystems Limited has announced “Form 605: Notice of ceasing to be a substantial holder.”
Read Form 605.
Positive independent review sets priority path to market for MagSense® Technology
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance